Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease

NCT03997097 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped New sponsor

Conditions

Single-ventricle
Pulmonary Hypertension
Univentricular Heart

Interventions

DRUG: Sildenafil
DRUG: Placebos

Sponsor

University Hospital, Montpellier